Search

Your search keyword '"polymyxin"' showing total 5,356 results

Search Constraints

Start Over You searched for: Descriptor "polymyxin" Remove constraint Descriptor: "polymyxin"
5,356 results on '"polymyxin"'

Search Results

1. Presence of Gut Microbiota Worsens D‐Galactosamine and Lipopolysaccharide‐Induced Hepatic Injury in Mice.

2. Advances in the clinical treatment of multidrug-resistant pathogens using polymyxins.

3. Environmental microbial colistin resistance in an elderly south Brazilian long-term care facility.

4. Potentially effective antimicrobial treatment for pneumonia caused by isolates of carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii complex species: what can we expect in the future?

5. Metabolic profiling unveils enhanced antibacterial synergy of polymyxin B and teixobactin against multi-drug resistant Acinetobacter baumannii.

6. Effects of Topical Polymyxin Neomycin Hydrocortison in Patients with Non-Allergic Rhinitis, a Randomized Clinical Trial.

7. Comparative study of colistin methanesulfonate and colistin sulfate/ polymyxin B in the treatment of ceftazidime-avibactam resistant Gram-negative bacilli infections.

8. In treacherous waters: detection of colistin-resistant bacteria in water and plastic litter from a recreational estuary.

9. 一株猪源摩氏摩根菌的分离鉴定与药物敏感性分析.

10. Relationship between antimicrobial use and the highest number of multidrug-resistant-Pseudomonas aeruginosa: a 10-year study.

11. Prevalence of polymyxin-resistant bacterial strains in India: a systematic review and meta-analysis.

12. Identification and Functional Analysis of ncRNAs Regulating Intrinsic Polymyxin Resistance in Foodborne Proteus vulgaris.

13. Real-world data on the effects of colistin sulfate and polymyxin B sulfate in the treatment of pneumonia induced by CR-GNB.

14. Development and Validation of Liquid Chromatographic Method for Fast Determination of Lincomycin, Polymyxin and Vancomycin in Preservation Solution for Transplants.

15. Mechanisms of gelofusine protection in an in vitro model of polymyxin Bassociated renal injury.

16. Evaluating virulence features of Acinetobacter baumannii resistant to polymyxin B.

17. Colistin versus polymyxin B for the treatment of carbapenem-resistant Klebsiella pneumoniae bloodstream infections.

18. Multiple factors trigger the formation and resuscitation of the VBNC state in alcohol-producing Klebsiella pneumoniae.

19. Structural and functional analysis of the Helicobacter pylori lipoprotein chaperone LolA

20. Transcriptomic analysis of induced resistance to polymyxin in carbapenem-resistant Enterobacter cloacae complex isolate carrying mcr-9

21. Combined therapeutic option for NDM-producing Serratia Marcescens – an in vitro study from clinical samples

22. Widespread fungal–bacterial competition for magnesium lowers bacterial susceptibility to polymyxin antibiotics.

23. Condensation methodology for quantification of Polymyxin B fluorimetrically: application to pharmaceutical formulations and greenness assessment.

24. Clinical Utility of Blood Culture Identification 2 Panel in Flagged Blood Culture Samples from the Intensive Care Unit of a Tertiary Care Hospital.

25. Combinatorial metabolic engineering of Bacillus subtilis for de novo production of polymyxin B.

26. Monotherapy vs combination therapy in patients with Klebsiella pneumoniae bloodstream infection: A systematic review and meta-analysis.

27. Polymyxin-induced neuromuscular weakness: a case report.

28. A novel major facilitator superfamily-type tripartite efflux system CprABC mediates resistance to polymyxins in Chryseobacterium sp. PL22-22A.

29. β-lactam-induced OMV release promotes polymyxin tolerance in Salmonella enterica sv. Typhi.

30. Ceftazidime-avibactam and aztreonam combination for Carbapenem-resistant Enterobacterales bloodstream infections with presumed Metallo-β-lactamase production: a systematic review and meta-analysis.

31. Ceftazidime-avibactam alone or in combination with Aztreonam versus Polymyxins in the management of carbapenem-Resistant Klebsiella pneumoniae nosocomial Infections (CAPRI study): a retrospective cohort study from South India.

32. Pharmacokinetics and Nephrotoxicity of Polymyxin MRX-8 in Rats: A Novel Agent against Resistant Gram-Negative Bacteria.

33. Enhancement of polymyxin B1 production by an artificial microbial consortium of Paenibacillus polymyxa and recombinant Corynebacterium glutamicum producing precursor amino acids

35. Activities of aztreonam in combination with several novel β-lactam-β-lactamase inhibitor combinations against carbapenem-resistant Klebsiella pneumoniae strains coproducing KPC and NDM.

36. Polyphosphate kinase regulates LPS structure and polymyxin resistance during starvation in E. coli.

37. Mechanistic and biophysical characterization of polymyxin resistance response regulator PmrA in Acinetobacter baumannii.

38. Tobramycin Reduces Pulmonary Toxicity of Polymyxin B via Inhibiting the Megalin-Mediated Drug Uptake in the Human Lung Epithelial Cells.

39. Acinetobacter baumannii: an evolving and cunning opponent.

40. Polymyxin B-targeted liposomal photosensitizer cures MDR A. baumannii burn infections and accelerates wound healing via M1/M2 macrophage polarization.

41. Ceftazidime–avibactam versus polymyxins in treating patients with carbapenem-resistant Enterobacteriaceae infections: a systematic review and meta-analysis.

42. Polymyxin Resistance in Salmonella : Exploring Mutations and Genetic Determinants of Non-Human Isolates.

43. Characteristics of non-carbapenemase producing carbapenem-resistant Klebsiella pneumoniae from a tertiary hospital in China.

44. Challenges in the Detection of Polymyxin Resistance: From Today to the Future.

45. Determining Susceptibility and Potential Mediators of Resistance for the Novel Polymyxin Derivative, SPR206, in Acinetobacter baumannii.

46. GATR-3, a Peptide That Eradicates Preformed Biofilms of Multidrug-Resistant Acinetobacter baumannii.

47. Correction: Review and analysis of the overlapping threats of carbapenem and polymyxin resistant E. Coli and Klebsiella in Africa.

49. Treatment of Central Nervous System Infection Caused by Multidrug-Resistant Acinetobacter baumannii with Intravenous and Intraventricular Colistin Sulfate: A Case Report and Literature Review

50. LPS adsorption and inflammation alleviation by polymyxin B-modified liposomes for atherosclerosis treatment

Catalog

Books, media, physical & digital resources